Sage’s Therapeutic Advances series of clinical journals was launched in 2008. Now comprising 20 journals, the Therapeutic Advances family has established itself as a high-quality gold open access series with internationally renowned Editorial Boards.
Many of the journals now have Impact Factors that place them in the first quartile in their respective fields; most are indexed in the Web of Science and other scholarly indexing services, and all are listed on PubMed soon after launch.
The journals are members of the Committee on Publication Ethics (COPE) and have stringent standards for research ethics and reporting. All articles undergo a thorough editorial evaluation and rigorous peer review, with a minimum of two independent experts. All articles are freely available via PubMed Central and the journal websites, driving high visibility and global exposure.
We invite you to explore the series and to get in touch with our Editors.
We are delighted to welcome Lauren Kelly, Bushra Mahdi, Jemima Williamson and Josh Gazmin to the Therapeutic Advances Team!
The Editors of Therapeutic Advances in Endocrinology and Metabolism are delighted to welcome Dr. Srikanth Bellary, Aston University, Birmingham, UK as the new Deputy Editor-in-Chief of our journal.
Therapeutic Advances in Medical Oncology has built a new sub-section of its Editorial Board – its Editorial Review Board – to help speed up peer-review while ensuring that quality of reviewer reports and journal ethical standards are upheld to the highest degree.
The Therapeutic Advances journals now publish video abstracts, plain language summaries and infographics alongside journal articles. Speak to the journal’s Editor to find out more.
The Therapeutic Advances series no longer accepts preclinical research, including basic laboratory research and animal studies
The Therapeutic Advances journals now accept Plain Language Summaries of Publications. You can find out more here: https://us.sagepub.com/en-us/nam/plain-language-summaries-of-publications-pls-p
Therapeutic Advances in Allergy and Rhinology
Therapeutic Advances in Cardiovascular Disease
Therapeutic Advances in
Chronic Disease
Therapeutic Advances in
Drug Safety
Managing Editor: Jemima Williamson, Sage Publishing
Re-Launched in 2023
Impact Factor: 2.2
Editor-In-Chief: Professor Arduino Mangoni, Flinders University, Australia
Managing Editor: Shasha Sharief, Sage Publishing
Impact Factor: 4.4
Follow @TADrugSafety
Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastrointestinal Endoscopy
Therapeutic Advances in Hematology
Editor-In-Chief: Professor Christoph Schindler, Hannover Medical School, Germany
Deputy Editor-In-Chief: Dr Srikanth Bellary, Aston University, Birmingham, UK
Managing Editor: Sarangi Thattyot Kariyath
Impact Factor: 3.8
Follow @OpenAccess_Endo
Executive Editor: Alessandro Baliani, Sage Publishing
Managing Editor: Josh Gazmin, Sage Publishing
Impact Factor: 4.2
Follow @TAGastroenterol
Editor-In-Chief: Professor Rami Eliakim, Sheba Medical Center, Israel
Executive Editor: Alessandro Baliani, Sage Publishing
Managing Editor: Jemima Williamson, Sage Publishing
Re-launched in 2019
Impact Factor: 2.6
Therapeutic Advances in Infectious Disease
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Musculoskeletal Disease
Therapeutic Advances in Neurological Disorders
Editor-In-Chief: Dr Andrés Henao-Martínez, School of Medicine, University of Colorado, USA
Managing Editor: Hemali Bedi, Sage Publishing
Impact Factor: 5.7
Follow @TAInfDis
Executive Editor: Georgia Patey, Sage Publishing
Managing Editor: Josh Gazmin, Sage Publishing
Impact Factor: 4.9
Follow @TAMedOncol
Editor-in-Chief: Professor Denis Poddubnyy, Charité Berlin University, Germany
Managing Editor: Jemima Williamson, Sage Publishing
Impact Factor: 4.2
Follow @TAMuscDis
Editor-In-Chief: Professor Ralf Gold, Ruhr University Bochum, Germany
Deputy Editor: Dr. Marinos C Dalakas, Thomas Jefferson University, Philadelphia, PA, USA
Executive Editor: Dr Hemi Malkki, Sage Publishing
Impact Factor: 5.9
Follow @TANeurolDisord
Therapeutic Advances in Ophthalmology
Therapeutic Advances in Psychopharmacology
Therapeutic Advances in
Rare Disease
Therapeutic Advances in Reproductive Health
Editor-In-Chief: Dr Joshua Cameron, FAAO, Western University of Health Sciences College of Optometry in Pomona, USA
Managing Editor: Sarangi Thattyot Kariyath, Sage Publishing
Launched in 2018
Impact Factor: 2.5
Follow @TAOphthalmology
Editor-In-Chief: Professor David Taylor, Maudsley Hospital, UK
Executive Editor: Dr Hemi Malkki, Sage Publishing
Managing Editor: Shasha Sharief, Sage Publishing
Impact Factor: 4.22
Follow @TAPsychopharm
Editor-In-Chief: Dr Tiina Urv, Division of Rare Diseases Research Innovation, NIH, USA
Managing Editor: Samantha Taylor, Sage Publishing
Launched in 2020
Follow @TARareDisease
Editor-In-Chief: Dr Zeev Blumenfeld, Rambam Medical Center, Israel
Managing Editor: Lauren Kelly, Sage Publishing
Launched in 2008
Impact Factor: 3.4
Follow @TARepHealth
Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Urology
Therapeutic Advances in Vaccines and Immunotherapy
Therapeutic Advances in Pulmonary and Critical Care Medicine
Editor-in-Chief: Sanjeev Madaan, Darent Valley Hospital, Dartford, UK
Impact Factor: 2.0
Follow @TA_Urology
Editor in Chief: Dr. Hussain Foda, Stony Brook State University, USA
Managing Editor: Lauren Kelly
Impact Factor: 2.0
Relaunched 2023